NPCE - Neuropace - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NPCE is currently covered by 7 analysts with an average price target of $17.16. This is a potential upside of $4.01 (30.49%) from yesterday's end of day stock price of $13.15.

Neuropace's activity chart (see below) currently has 35 price targets and 41 ratings on display. The stock rating distribution of NPCE is 19.05% HOLD and 80.95% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.77% with an average time for these price targets to be met of 125.86 days.

Highest price target for NPCE is $17, Lowest price target is $13, average price target is $17.2.

Most recent stock forecast was given by ROBBIE MARCUS from JPMORGAN on 14-May-2025. First documented stock forecast 17-May-2021.

Currently out of the existing stock ratings of NPCE, 4 are a HOLD (19.05%), 17 are a BUY (80.95%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$16

$2.85 (21.67%)

$14

24 days ago
(14-May-2025)

4/5 (80%)

$0.4 (2.56%)

127

Buy

$17

$3.85 (29.28%)

$20

24 days ago
(14-May-2025)

4/5 (80%)

$1.4 (8.97%)

179

Buy

$13

$-0.15 (-1.14%)

$15

6 months 25 days ago
(13-Nov-2024)

2/2 (100%)

$3.85 (42.08%)

171

Buy

$20

$6.85 (52.09%)

$20

1 years 1 months 1 days ago
(06-May-2024)

3/5 (60%)

$6.53 (48.48%)

121

Buy

$20

$6.85 (52.09%)

$16

1 years 2 months 24 days ago
(14-Mar-2024)

5/8 (62.5%)

$6.37 (46.74%)

266

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NPCE (Neuropace) average time for price targets to be met?

On average it took 125.86 days on average for the stock forecasts to be realized with a an average price target met ratio 60.77

Which analyst has the current highest performing score on NPCE (Neuropace) with a proven track record?

ROSS OSBORN

Which analyst has the current lower performing score on NPCE (Neuropace) with a proven track record?

MIKE POLARK

Which analyst has the most public recommendations on NPCE (Neuropace)?

Ross Osborn works at CANTOR FITZGERALD and has 9 price targets and 7 ratings on NPCE

Which analyst is the currently most bullish on NPCE (Neuropace)?

Mike Polark with highest potential upside - $11.39

Which analyst is the currently most reserved on NPCE (Neuropace)?

Vik Chopra with lowest potential downside - -$0.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?